Preoperative assessment of peritoneal carcinomatosis: Intraindividual comparison of 18F-FDG PET/CT and MRI

Abdominal Imaging

Volumn 38, Issue 1, 2013, Pages 64-71

  Klumpp, Bernhard Daniel ^a   Schwenzer, Nina ^a   Aschoff, Philip ^b   Miller, Stephan ^c   Kramer, Ulrich ^a   Claussen, Claus D ^a   Bruecher, Bjoern ^a   Koenigsrainer, Alfred ^a   Pfannenberg, Christina ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Diakonie Klinikum Stuttgart   (Germany)

^c Radiologiepraxis Dr Aicher   (Germany)

Author keywords

HIPEC; MRI; Peritoneal carcinomatosis; Peritonectomy; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM CHELATE; IOPROMIDE; MANNITOL; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

CARCINOMA; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84872685385     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9881-7     Document Type: Article

References (32)

1. Sadeghi B, Arvieux C, Glehen O, et al. (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363 (Pubitemid 30051820)
2. Pyrhoenen S, Kuitunen T, Nyandoto P, Kouri M (1995) Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587-591
3. Hamilton T, Lanuke K, Mack LA, Temple WJ (2011) Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg 201(5):650-654
4. Raue W, Tsilimparis N, Langelotz C, et al. (2011) Initial results after implementation of multimodal treatment for peritoneal malignancies. Acta Chir Belg 111(2):68-72
5. Gill RS, Al-Adra DP, Nagendran J, et al. (2011) Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol 104:692-698
6. Esquivel J, Elias D, Baratti D (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98:263-267
7. Testa A, Ludovisi M, Mascilini F, et al. (2011) Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 39:99-105
8. Forstner R (2007) Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17:3223-3246 (Pubitemid 350142347)
9. Pfannenberg C, Koenigsrainer I, Aschoff P, et al. (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 16:1295-1303
10. Low RN, Barone RM, Lacey C, et al. (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513-520 (Pubitemid 27337505)
11. Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267-283 (Pubitemid 47077103)
12. Low RN, Sigeti JS (1994) MR imaging of peritoneal disease: comparison of contrast enhanced fast multiplanar spoiled gradient recalled and spin echo imaging. Am J Roentgenol 163:1131-1140 (Pubitemid 24355706)
13. Glaspy JA, Hawkins R, Hoh CK, Phelps ME (1993) Use of positron emission tomography in oncology. Oncology 7:41-55
14. Kole AC, Nieweq OE, Pruim J, et al. (1998) Detection of unknown occult primary tumors using positron emission tomography. Cancer 82:1160-1166 (Pubitemid 28136532)
15. Chopra S, Laurie LR, Chintapalli KN, Valente PT, Dodd GD 3rd (2000) Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation. J Comput Assist Tomogr 24:395-399 (Pubitemid 32203929)
16. Hideo M, Aoki J, Taketomi A, Sato N, Endo K (2004) Serous surface papillary carcinoma of the peritoneum: clinical, radiologic and pathologic findings in 11 patients. Am J Roentgenol 183:923-928 (Pubitemid 44185074)
17. Furukawa T, Ueda J, Takahashi S, et al. (1999) Peritoneal serous papillary carcinoma: radiological appearance. Abdom Imaging 24:78-81 (Pubitemid 29036858)
18. Stafford-Johmson DB, Bree RL, Francis IR, Korobkin M (1998) CT appearance of primary serous carcinoma of the peritoneum. Am J Roentgenol 171:687-689 (Pubitemid 28406130)
19. Zissin R, Hertz M, Shapiro-Feinberg M, et al. (2001) Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 56:740-745 (Pubitemid 35023798)
20. Brown G, Kirkham A, Williams GT, et al. (2004) High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. Am J Roentgenol 182:431-439 (Pubitemid 38116588)
21. De laco P, Musto A, Orazi L, et al. (2010) FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol 80:e98-e103
22. Berthelot C, Morel O, Girault S, et al. (2011) Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy. Nucl Med Commun 32:23-29
23. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631-1636 (Pubitemid 23249290)
24. Sala E, Kataoka M, Pandit-Taskar N, et al. (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology 257:125-134
25. Rakheja R, Makis W, Hickeson M (2011) Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT. Abdom Imaging. doi: 10.1007/s00261-011- 9722-0
26. 18F]FDG-PET/ CT. Abdom Imaging 35:701-707
27. Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694-700
28. Iafrate F, Ciolina M, Sammartino P, et al. (2011) Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging. Abdom Imaging [Epub]
29. Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33:87-93
30. Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS (1999) Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology 210:625-632 (Pubitemid 29124019)
31. Priest AN, Gill AB, Kataoka M, et al. (2010) Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease. Magn Reson Med 63:1044-1049
32. Satoh Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT diffusion-weighted MRI and contrast-enhanced MDCT. Am J Roentgenol 196:447-453